TriVascular Technologies, the only Bay Area company going public this week, fell short of its IPO target but raised $78 million in the latest sign of weakness in the market for new stocks. The Santa Rosa company led by CEO Christopher Chavez sold 6.5 million shares at $12, below the expected range of between $13 and $15. It was one of three U.S. companies to miss their marks on Tuesday.
Help employers find you! Check out all the jobs and post your resume.
